Skip to main content
logo
NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Aug 31, 2026, 9:52 AM EST

NKGen Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
02460--
Market Cap Growth
-97.47%-60.80%---
Enterprise Value
385271--
Last Close Price
0.000.662.759.959.69

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-0.01-0.34-1.03--

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.76-0.76-0.347.70-1.37
Net Debt / Equity Ratio
-0.76-0.75-0.347.62-1.36
Net Debt / EBITDA Ratio
-1.68-2.05-0.70-0.51-2.49
Net Debt / FCF Ratio
-1.94-2.53-0.91-0.53-2.59
Asset Turnover
---0.00-
Quick Ratio
0.000.000.000.010.01
Current Ratio
0.050.040.050.020.01
Return on Assets (ROA)
-93.33%-103.04%-113.32%-88.47%-
Return on Capital Employed (ROCE)
85.60%64.60%129.50%-1532.20%58.00%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8588.04%-187.66%-137.81%--
FCF Yield
-7163.51%-88.48%-36.46%--
Buyback Yield / Dilution
-98.13%-86.88%-142.70%55.40%-